[Congressional Record Volume 172, Number 48 (Tuesday, March 17, 2026)]
[Senate]
[Page S1093]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

      By Mr. REED (for himself, Mr. Scott of South Carolina, Ms. Smith, 
        and Mr. Lankford):
  S. 4109. A bill to reauthorize the Stem Cell Therapeutic and Research 
Act of 2005, and for other purposes; to the Committee on Health, 
Education, Labor, and Pensions.
  Mr. REED. Mr. President, today, I am pleased to introduce the Stem 
Cell Therapeutic and Research Reauthorization Act of 2026 with Senators 
Tim Scott, Tina Smith, and James Lankford.
  Our bipartisan bill will reauthorize the C.W. Bill Young National 
Marrow Donor Program and the National Cord Blood Inventory, which help 
individuals diagnosed with leukemia and lymphomas, sickle cell anemia, 
and rare genetic blood disorders find suitable bone marrow or umbilical 
cord blood donors.
  More than 18,000 individuals are diagnosed with diseases like blood 
cancer and sickle cell disease each year and hope for a blood stem cell 
or bone marrow transplant to help treat or even cure their disease. 
Since the 1980s, the public registries created under these programs 
have been a lifeline for the more than 75 percent of Americans who do 
not have a matched donor in their families. By strengthening and 
enhancing the important programs operating these registries, many more 
Americans will be afforded the opportunity to find a match if they are 
ever in need.
  I look forward to swift consideration of this legislation in the 
Senate Health, Education, Labor, and Pensions Committee and working 
toward passage in the full Senate.
                                 ______